These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 32305052

  • 1. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
    Xu C, Zhai J, Fu Y.
    Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
    [Abstract] [Full Text] [Related]

  • 2. Long non-coding RNA CDKN2B-AS1 enhances LPS-induced apoptotic and inflammatory damages in human lung epithelial cells via regulating the miR-140-5p/TGFBR2/Smad3 signal network.
    Wang B, Sun Q, Ye W, Li L, Jin P.
    BMC Pulm Med; 2021 Jun 14; 21(1):200. PubMed ID: 34126975
    [Abstract] [Full Text] [Related]

  • 3. Long noncoding RNA CDKN2B-AS1 interacts with miR-411-3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway.
    Wang Y, Huang Y, Liu H, Su D, Luo F, Zhou F.
    Biochem Biophys Res Commun; 2019 Jun 18; 514(1):44-50. PubMed ID: 31014670
    [Abstract] [Full Text] [Related]

  • 4. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p.
    Chen X, Xiong D, Yang H, Ye L, Mei S, Wu J, Chen S, Shang X, Wang K, Huang L.
    J Cell Physiol; 2019 Apr 18; 234(4):5264-5275. PubMed ID: 30341904
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer.
    Ge C, Dong J, Chu Y, Cao S, Zhang J, Wei J.
    Aging (Albany NY); 2020 Jul 16; 12(14):14355-14364. PubMed ID: 32675387
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Upregulated lncRNA Cyclin-dependent kinase inhibitor 2B antisense RNA 1 induces the proliferation and migration of colorectal cancer by miR-378b/CAPRIN2 axis.
    Zheng Y, Zeng J, Xia H, Wang X, Chen H, Huang L, Zeng C.
    Bioengineered; 2021 Dec 16; 12(1):5476-5490. PubMed ID: 34511033
    [Abstract] [Full Text] [Related]

  • 9. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma.
    Dasgupta P, Kulkarni P, Majid S, Hashimoto Y, Shiina M, Shahryari V, Bhat NS, Tabatabai L, Yamamura S, Saini S, Tanaka Y, Dahiya R.
    Cell Death Dis; 2020 Aug 19; 11(8):660. PubMed ID: 32814766
    [Abstract] [Full Text] [Related]

  • 10. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H, Zhu C, He Z, Chen S, Li L, Sun C.
    J Exp Clin Cancer Res; 2020 Sep 05; 39(1):179. PubMed ID: 32891166
    [Abstract] [Full Text] [Related]

  • 11. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
    Sun J, Min H, Yu L, Yu G, Shi Y, Sun J.
    Anticancer Drugs; 2021 Jan 01; 32(1):11-21. PubMed ID: 33290312
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. LncRNA CDKN2B-AS1 contributes to glioma development by regulating the miR-199a-5p/DDR1 axis.
    Lu J, Chen Y, Wen L, Zhou Q, Yan S.
    J Gene Med; 2022 Jan 01; 24(1):e3389. PubMed ID: 34559933
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH, Yu JH, Yang B, Gong FC, Zhang KW.
    Eur Rev Med Pharmacol Sci; 2019 Dec 01; 23(23):10400-10409. PubMed ID: 31841194
    [Abstract] [Full Text] [Related]

  • 19. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer.
    Ji L, Fan X, Zhou F, Gu J, Deng X.
    J Cell Physiol; 2020 Apr 01; 235(4):3669-3678. PubMed ID: 31587286
    [Abstract] [Full Text] [Related]

  • 20. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
    Chen S, Li K.
    BMC Cancer; 2020 Sep 25; 20(1):924. PubMed ID: 32977766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.